Business Context and Reporting Period
Supercom Ltd., a foreign private issuer based in Tel Aviv, Israel, filed this Form 6-K on January 22, 2024, covering the month of January 2024. The filing details a specific corporate action taken on January 19, 2024, to resolve pending litigation.
Key Financial Metrics
This filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a capital transaction involving the issuance of equity and warrants.
Material Changes and Corporate Actions
On January 19, 2024, Supercom Ltd. issued securities to Sabby Volatility Warrant Master Fund, Ltd. ("Sabby") to fully settle pending legal actions in the Supreme Court of New York, New York County. The issuance included:
- Ordinary Shares: 1,475,142 shares (par value NIS 2.5 per share).
- Warrants: 4,250,000 two-year warrants to purchase Ordinary Shares at an exercise price of $0.45 per share.
- Pre-Funded Warrants: 5,524,858 pre-funded warrants to purchase Ordinary Shares at an exercise price of $0.00001 per share.
All securities are exercisable immediately, subject to beneficial ownership blockers. The issuance was executed under an exemption pursuant to Section 3(a)(10) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The primary contingency addressed is the resolution of the specific legal dispute with Sabby, which has now been settled through the issuance of the described securities.
Investor Verification Checklist
- Verify the total dilution impact of the 1,475,142 ordinary shares and 5,524,858 pre-funded warrants on existing shareholders.
- Review the attached Exhibits 4.1 and 4.2 for specific terms regarding beneficial ownership blockers and warrant exercise conditions.
- Confirm the status of the previously pending litigation in the Supreme Court of New York to ensure full settlement.
- Assess the potential future cash inflow from the exercise of the 4,250,000 warrants at $0.45 per share.